Edwards Lifesciences Insider Daniel Lippis Buys 1,019 Shares Amid JenaValve Deal, Sparking Social‑Media Surge and Market Optimism
Insider buying by Edwards Lifesciences’ chief valuation pro signals confidence amid a near 52‑week high and potential JenaValve deal, boosting investor optimism.
3 minutes to read